- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Embattled Embryo Researcher Quits Georgetown
4 February 1997 8:00 pm
WASHINGTON--Mark Hughes, an internationally known leader in DNA diagnostics, has resigned from Georgetown University after coming under fire for allegedly failing to honor a ban on human embryo research. Until his resignation--which occurred on 24 January but was only disclosed this week--Hughes was director of Georgetown's Institute of Molecular and Human Genetics.
Hughes ran into conflict with the university and his former sponsor, the National Institutes of Health (NIH), over his efforts to diagnose genetic diseases--such as Tay-Sachs disease and cystic fibrosis--in test-tube embryos scheduled for implantation (Science, 24 January, p. 472). By testing the DNA of one cell from an eight-cell human embryo, Hughes could determine whether the embryo would be affected by the disease, giving parents the option of not implanting it.
NIH determined, however, that a congressional ban on human embryo research prohibited it from supporting this work. Hughes says he kept the embryo work separate from his NIH-sponsored studies. But NIH sources say that some of Hughes's NIH-supported staff complained that he involved them in embryo testing. Last October, after inquiring into these complaints, NIH stopped funding Hughes. When this news appeared in the press last month, Georgetown began its own inquiry to determine whether Hughes's work violated the university's policy of not supporting studies that could lead to an embryo being discarded. While the inquiry was still under way, Hughes resigned.
Hughes could not be reached for comment, but Georgetown made public a copy of his resignation letter. "Recent events," Hughes writes, "make clear that I cannot continue my preimplantation genetic diagnosis work while serving as a Georgetown faculty member. This work is of crucial importance to me and, I believe, to prospective parents around the world. Accordingly, I am resigning my faculty position. ..." Hughes adds that he intends to continue his research at other unnamed facilities.
Georgetown issued no statement but released a memo to the faculty from Sam Wiesel, executive vice president for health sciences, noting that the university had accepted Hughes's resignation and had appointed cancer researcher Mark Lippman as interim director of the genetics institute. Weisel's note also praises Hughes for helping to found the institute and recruiting "a number of new faculty."